Members and friends of Virginia Bio,
The convergence of bio with IT and big data is well described. Indeed most of you know it firsthand. This week I seemed to see it everywhere I went. To start with, a global pharma company’s 4 hour briefing on its future vision of new drug development – one planted on deep phenotyping and proven specific biomarkers requiring the skills and technologies of big data. Later, I met two different startup companies, one in diagnostics and the other in neuroimaging, and both based on a facility and intelligence in gathering, shaping and gaining insights from massive datasets. I’ve had or heard conversations with health care providers striving to harness those same technologies and capabilities to mine clinical records and real world data to discover how to deploy bio, pharma, device and diagnostic innovations to select the most effective care to patients and to provide it efficiently.
Like many others, I believe this convergence presents our members, the Virginia bioscience community, and the Commonwealth itself, with an historic strategic opportunity because of Virginia’s unrivaled IT/big data assets and expertise. I want Virginia Bio to do everything we can to accelerate and enable this convergence, to grow our bioscience industry and to help our talent here take a place at the leading edge across the nation and world.
Very soon we will be announcing details for our next statewide gathering on April 23, 2015 at the Westfields Marriott, in Chantilly. When 550 of us met last year in Charlottesville, we celebrated all you have achieved over the past twenty years. Next spring, we want to take that enthusiasm and focus it forward. One goal of the event, given the special opportunity provided by the northern Virginia setting, is to bring Virginia bio and big data/IT communities - researchers, companies, investors, consultants, together in a way never been done before. Let’s shine light on needs, opportunities and capabilities, make new contacts and build that community.
We’re using our Virginia Bio Commercialization luncheon series to push this goal too. Recall that this monthly event, though staged in Richmond, is available to members through live streaming statewide and archived in the video library on our website. The program on October 9 will be "The sky is the limit: the data-driven, data-smart bioscience organization.” Experts will challenge the audience with ideas and examples to use the latest in data tools, techniques and strategies to transform your biotech company to become all it can be – strategic, innovative, competitive, effective, efficient and insightful in a way never before possible. Panelists include Jay Goldman, Managing Director Sensei Labs, senior leader Klick Health, and co-author of the New York Times bestseller The Decoded Company, and Lewis Broome, CEO of Data Blueprint, a Richmond-based data management consulting firm. Go to our Community Calendar page for more details and to register.
I would love to hear from you with ideas about other ways Virginia Bio can help Virginia join the lead in this extraordinary new age of bioscience research and commercialization.